The weapon is not a new drug but a ground-breaking computer-modelling tool.

‘The priority for assistance commissioners in treating psoriasis is to achieve the greatest pathways of care – to make certain that the right sufferers are becoming treated in the proper place at the right time to get the best feasible outcomes. Treating successfully in primary treatment is better for the patient and in addition means secondary care assets can be concentrated on the most likely cases. Tools such as this are the real way forward to help clinicians review services, optimise treatment and keep better control of costs.’ ‘Psoriasis and Me’ works by comparing specific local data inputs – such as population size, waiting moments for referrals to secondary care and the types and costs of treatments currently used – to stored country-specific info and the Psoriasis Region and Severity Index .